Elizabeth Holmes of Theranos Speaks at AACC To Skeptical PhDs, Pathologists, and Press

By Robert Michel | From the Volume XXIII No. 11 – August 15, 2016 Issue

CEO SUMMARY: Elizabeth Holmes, Founder and CEO of Theranos, Inc., was given the ideal platform by AACC to show the science behind her lab company’s much-touted diagnostic technologies. But in a surprise to the assembled audience, Holmes, accompanied by three PhDs on her team, chose to d…

Read More

---

Score for Theranos after AACC: Fail.

By Mary Van Doren | From the Volume XXIII No. 11 – August 15, 2016 Issue

This is an excerpt from a 1,600-word article in the August 15 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. …

Read More

---

Walgreens Tells Theranos: ‘Lab Deal Is Terminated’

By Robert Michel | From the Volume XXIII No. 8 – June 13, 2016 Issue

BREAKING NEWS: As this issue of THE DARK REPORT went to press, it was learned that Walgreens had announced the termination of its lab testing agreement with Theranos, effective immediately. Theranos loses access to about 40 Walgreens pharmacies in Phoe…

Read More

---

Is Theranos Kowtowing To CMS over Pending CLIA Sanctions?

By Robert Michel | From the Volume XXIII No. 7 – May 23, 2016 Issue

CEO SUMMARY: Having ignored the profession of laboratory medicine for nearly all of its 13-year corporate life, Theranos suddenly began engaging with expert laboratorians last month. The timing of this new outreach coincides with public disclosure that CMS proposed the severest sanctions …

Read More

---

Washington Post: Theranos Approached Military in 2012

By Joseph Burns | From the Volume XXII, Number 17 – December 7, 2015 Issue

SINCE THE WALL STREET JOURNAL published its exposé of Theranos Inc. in October, other media outlets have published the findings of their own investigations into various aspects of the lab company’s practices. One example is the disclosure by The Wall Street …

Read More

---

WSJ ‘Sticks’ Theranos, Raises Serious Questions

By Robert Michel | From the Volume XXII No. 15 – October 26, 2015 Issue

CEO SUMMARY: Following months of investigation, reporter John Carreyrou of The Wall Street Journal published back-to-back reports about aspects of Theranos that the…

Read More

---

Newer, Smaller Analyzers Will Bring Big Data to Labs

By Joseph Burns | From the Volume XXII No. 10 – July 13, 2015 Issue

CEO SUMMARY: Clinical laboratories of all sizes are poised to become the source of much of a hospital or health system’s “big data.” At many academic center labs, greater use of genetic and molecular testing requires that more space and more staff be devoted to data management. A…

Read More

---

Level Two of Value Pyramid Defines Internal Benchmarks

By Robert Michel | From the Volume XXI No.16 – November 24, 2014 Issue

CEO SUMMARY: In this second installment of our series on the laboratory value pyramid, we introduce “Level Two: Establish and Meet Standards of Value.” This second level continues the lab’s focus on its internal operations and activities. The goal is for the lab to develop the working cultu…

Read More

---

‘Game Changer’ Mass Spectrometry for Microbiology at UNC

By Joseph Burns | From the Volume XXI No. 8 – June 9, 2014 Issue

CEO SUMMARY: Microbiologists at the University of North Carolina are using MALDI-TOF mass spectrometry to slash the time to answer and significantly cut lab costs. Their goals are to improve patient outcomes and reduce average length of stay. In a one-year study presented last month, UNC …

Read More

---

One Key to Lab Success Is Daily Performance Metrics

By Joseph Burns | From the Volume XXI No. 7 – May 19, 2014 Issue

CEO SUMMARY: Every clinical lab today must deal with the twin challenges of performing an increased volume of tests while being paid less money. That’s why a handful of innovative lab organizations now use management information systems with analytics that provide detailed, real-time me…

Read More

---